We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.2B
AUM Growth
+$4.78B
Cap. Flow
+$3.57B
Cap. Flow %
23.39%
Top 10 Hldgs %
44.86%
Holding
2,187
New
553
Increased
436
Reduced
404
Closed
789

Top Sells

Rank Stock Value
1
VMW
VMware, Inc
VMW
+$95.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$89.4M
3
XOM icon
ExxonMobil
XOM
+$84.7M
4
SO icon
Southern Company
SO
+$79.2M
5
EMR icon
Emerson Electric
EMR
+$61.3M

Sector Composition

Rank Sector Weight
1 Technology 9.26%
2 Industrials 7.84%
3 Utilities 7.6%
4 Healthcare 5.4%
5 Real Estate 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWK icon
1576
Cushman & Wakefield Ltd
CWK
$3.48B
-54,078
Closed -$412K
DAL icon
1577
Delta Air Lines
DAL
$54.2B
-473,809
Closed -$17.5M
DAN icon
1578
Dana Inc
DAN
$3.41B
-102,368
Closed -$1.5M
DASH icon
1579
DoorDash
DASH
$96.8B
-71,188
Closed -$5.66M
DDOG icon
1580
Datadog
DDOG
$84.6B
-7,210
Closed -$657K
DE icon
1581
Deere & Co
DE
$175B
-8,771
Closed -$3.31M
DEA
1582
Easterly Government Properties
DEA
$1.16B
-10,706
Closed -$306K
DFS
1583
DELISTED
Discover Financial Services
DFS
-3,064
Closed -$265K
DGII icon
1584
Digi International
DGII
$2.84B
-7,849
Closed -$212K
DHC
1585
PUT
Diversified Healthcare Trust
DHC
$1.94B
-630,700
Closed -$1.22M
DHR icon
1586
Danaher
DHR
$154B
-109,328
Closed -$24M
DLR icon
1587
Digital Realty Trust
DLR
$70.5B
-227,751
Closed -$27.6M
DLTR icon
1588
Dollar Tree
DLTR
$25.3B
-41,517
Closed -$4.42M
DNLI icon
1589
Denali Therapeutics
DNLI
$3.98B
-17,381
Closed -$359K
DOCS icon
1590
Doximity
DOCS
$4.51B
-74,072
Closed -$1.57M
DOW icon
1591
Dow Inc
DOW
$23.4B
-13,711
Closed -$707K
DRH icon
1592
Diamondrock Hospitality Co
DRH
$2.62B
-88,742
Closed -$713K
DSGX icon
1593
Descartes Systems
DSGX
$6.7B
-9,747
Closed -$715K
DTM icon
1594
DT Midstream
DTM
$12.9B
-10,311
Closed -$546K
DUK icon
1595
Duke Energy
DUK
$93.4B
-520,446
Closed -$45.9M
DVA icon
1596
DaVita
DVA
$11.1B
-7,212
Closed -$682K
DVAX
1597
DELISTED
Dynavax Technologies
DVAX
-81,806
Closed -$1.21M
DX
1598
Dynex Capital
DX
$3.23B
-39,864
Closed -$476K
DXPE icon
1599
DXP Enterprises
DXPE
$2.95B
-25,349
Closed -$886K
DXLG icon
1600
Destination XL Group
DXLG
$33.7M
-42,489
Closed -$190K

Similar funds

Michael Gelband's Q4 2023 Portfolio in Review

As of Q4 2023, Michael Gelband held 2,187 positions worth $15.2B, up 46% from $10.5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Michael Gelband deployed $3.57B of net new capital in Q4 2023, opening 553 new positions and adding to 436 existing holdings. Its largest new stake was Fidelity National Information Services: 6,650,397 shares worth $399M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 10% a quarter earlier, followed by Industrials and Utilities.

On the sell side, the largest reduction was Merck, an estimated $48.2M trimmed.

  • Michael Gelband's largest Q4 2023 buy was Fidelity National Information Services: 6,650,397 shares worth $399M.
  • Michael Gelband added most to Global Payments in Q4 2023, an estimated $250M increase.
  • Michael Gelband's biggest Q4 2023 reduction was Merck, cutting an estimated $48.2M.
  • Michael Gelband fully exited VMware, Inc in Q4 2023, selling an estimated $95.7M.
  • Michael Gelband's ten largest holdings make up 45% of its $15.2B portfolio in Q4 2023.
  • Michael Gelband opened 553 new positions and closed 789 in Q4 2023.
  • Michael Gelband's portfolio value rose 46% quarter-over-quarter to $15.2B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.